P

PathAI

Boston company selling the AISight digital pathology platform (with an FDA 510(k)-cleared and a CE-IVDR-marked Dx version) and AI pathology algorithms for biopharma research and clinical trials.

StageUndisclosed

Founded—

HeadquartersBoston, USA

StatusPrivate

Products

Selected offerings — the AI products recorded here, not the vendor's full catalogue.

• AISight Platform

  Digital pathology platform with an image management system (research use), AISight Dx (FDA 510(k) cleared, and CE-IVDR marked) and AI algorithm products for biopharma translational research and clinical development.

Inside AISight

• ArtifactDetect Application Included with the parent

  ArtifactDetect automatically detects and highlights artifacts that may affect slide evaluations.

• TumorDetect Application Included with the parent

  TumorDetect analyzes whole-slide images to identify cases with likely tumors for prioritization.

• AIM-TumorCellularity Application Included with the parent

  AIM-TumorCellularity quantifies tumor and tissue areas to support tumor cellularity assessment.

• AIM-IHC Breast Panel Application Included with the parent

  AIM-IHC Breast Panel provides AI-generated scoring of breast cancer biomarkers HER2, ER, PR, and Ki-67.

• AIM-PD-L1 Application Included with the parent

  AIM-PD-L1 detects and quantifies PD-L1-positive tumor and immune cells in pathology images.

Inside AISight Clinical Trials

• AIM-HI Ulcerative Colitis Application Included with the parent

  AIM-HI Ulcerative Colitis provides AI-assisted histologic scoring for ulcerative colitis clinical trial assessment and research.

Similar products 8

No sourced competitor yet: no filing, vendor document or measured-market report read so far names a rival for this company, so none is asserted. The companies below are the closest by what their products do.

How this list is ranked ↗

SHSiemens HealthineersPublicAIM-HI Ulcerative Colitis and AI-Rad Companion both list medical imaging analysis; scale not recorded for either.1 of 1 capabilityShared product typeCompareLLunitPublicAIM-IHC Breast Panel and Lunit INSIGHT CXR both list medical imaging analysis; scale not recorded for either.1 of 1 capabilityShared product typeCompareTATempus AIPublicAIM-IHC Breast Panel and Tempus ECG-AF both list medical imaging analysis; PathAI's scale not recorded.1 of 1 capabilityShared product typeCompareAAidocLate-stageAISight and Aidoc aiOS both list medical imaging analysis; scale not recorded for either.1 of 1 capabilityShared product typeCompareWWaivEarly-stageAISight and TLS Detect both list medical imaging analysis; scale not recorded for either.1 of 1 capabilityShared product typeCompareHCHuawei CloudUndisclosedAISight and EIHealth both list medical imaging analysis; scale not recorded for either.1 of 1 capabilityShared product typeCompareEEncordUndisclosedAISight and Encord both list medical imaging analysis; scale not recorded for either.1 of 1 capabilityShared product typeCompareZZEISSUndisclosedAIM-HI Ulcerative Colitis and ZEISS CIRRUS PathFinder both list medical imaging analysis; scale not recorded for either.1 of 1 capabilityShared product typeCompare

Closest alternatives are pairs a vendor page itself compares. Similar products are matched from what each product does; nothing in that group is asserted as a rivalry.

Sources

Total funding

Not found · 13 Oct 2026

Pages read for this record state no funding total.

Valuation

Not found · 13 Oct 2026

Pages read for this record state no valuation.

Founded

Not found · 13 Oct 2026

Pages read for this record state no founding year.

Public listing

Company disclosure · 13 Oct 2026

PathAI, Inc.; no listing on the pages read; treated as private.

Description

Official documentation · 13 Oct 2026

Homepage navigation: AISight Digital Pathology Platform, AISight Dx (FDA 510(k) cleared; CE-IVDR marked), IHCExplore, PathExplore, LiverExplore, IBDExplore.

Open PathAI in the directory

Something wrong here? Send a correction — quote this company id: pathai.